Haleon Balance Sheet Health
Financial Health criteria checks 2/6
Haleon has a total shareholder equity of £16.7B and total debt of £8.9B, which brings its debt-to-equity ratio to 53.4%. Its total assets and total liabilities are £33.4B and £16.7B respectively. Haleon's EBIT is £2.4B making its interest coverage ratio 6.5. It has cash and short-term investments of £531.0M.
Key information
53.4%
Debt to equity ratio
UK£8.93b
Debt
| Interest coverage ratio | 6.5x |
| Cash | UK£531.00m |
| Equity | UK£16.71b |
| Total liabilities | UK£16.69b |
| Total assets | UK£33.40b |
Recent financial health updates
No updates
Recent updates
Haleon: Defensive Consumer Healthcare Stock As Safe Haven
Aug 06The Investment Case For Haleon: Steady Shareholder Value Accumulation
Nov 20The Share Price Has The Flu, But Haleon Is As Healthy As An Ox
Sep 07Haleon: A Hidden Gem In The Consumer Health Market
Jun 12Haleon exploring sale of ChapStick Brand - report
Feb 25Haleon said to evaluate potential deals to increase its size - report
Jan 31Haleon: Undervalued With Clear Catalyst Ahead
Aug 31Former GSK consumer health unit Haleon hits all-time low
Aug 19Haleon CEO says brand recognition, gross margins will drive growth - CNBC
Jul 20Financial Position Analysis
Short Term Liabilities: HLN's short term assets (£4.7B) do not cover its short term liabilities (£5.6B).
Long Term Liabilities: HLN's short term assets (£4.7B) do not cover its long term liabilities (£11.1B).
Debt to Equity History and Analysis
Debt Level: HLN's net debt to equity ratio (50.3%) is considered high.
Reducing Debt: Insufficient data to determine if HLN's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: HLN's debt is well covered by operating cash flow (24.6%).
Interest Coverage: HLN's interest payments on its debt are well covered by EBIT (6.5x coverage).